Cargando…
Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients?
BACKGROUND: To evaluate the efficacy of switching from insulin to the GLP-1 receptor agonist liraglutide in type 2 diabetes mellitus patients. METHODS: The subjects were 231 outpatients with type 2 diabetes mellitus being treated with liraglutide for the first time. For 161 patients, liraglutide was...
Autores principales: | Kawata, Takehiro, Kanamori, Akira, Kubota, Akira, Maeda, Hajime, Amamiya, Hikaru, Takai, Masahiko, Kaneshige, Hideaki, Minagawa, Fuyuki, Iemitsu, Kotaro, Kaneshiro, Mizuki, Ishikawa, Masashi, Takeda, Hiroshi, Takuma, Tetsurou, Mokubo, Atsuko, Machimura, Hideo, Obana, Mitsuo, Miyakawa, Masaaki, Naka, Yoshikazu, Suzuki, Daisuke, Terauchi, Yasuo, Toyoda, Masao, Tanaka, Yasushi, Matsuba, Ikuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935523/ https://www.ncbi.nlm.nih.gov/pubmed/24578756 http://dx.doi.org/10.14740/jocmr1719w |
Ejemplares similares
-
Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
por: Kubota, Akira, et al.
Publicado: (2012) -
Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study
por: Umezawa, Shinichi, et al.
Publicado: (2015) -
Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients
por: Kubota, Akira, et al.
Publicado: (2012) -
Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study
por: Matsuba, Ikuro, et al.
Publicado: (2020) -
Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K Study
por: Ishikawa, Masashi, et al.
Publicado: (2015)